Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study assesses the aerosol delivery characteristics (measured by in vivo lung
deposition, nebulization time, serum tobramycin concentrations, and pharmacokinetic
parameters) and safety of tobramycin inhalation solution administered for inhalation by PARI
eFlow rapid electronic nebulizer (no compressor) vs. PARI LC PLUS Jet Nebulizer (with
compressor) in healthy subjects and in subjects with cystic fibrosis.